United States · Financial press · Investor's Business Daily
IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside
Mizuho analysts raised its price target ahead of Cardinal Health's earnings. The stock is testing a buy point after topping another entry. The post IBD Stock Of The Day Tests New…
Read the full article on Investor's Business Daily Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)